211 related articles for article (PubMed ID: 22436581)
1. Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease.
Yu LH; Morimura T; Numata Y; Yamamoto R; Inoue N; Antalfy B; Goto Y; Deguchi K; Osaka H; Inoue K
Mol Genet Metab; 2012 May; 106(1):108-14. PubMed ID: 22436581
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of endoplasmic reticulum stress in Pelizaeus-Merzbacher disease by an anti-malaria drug, chloroquine.
Morimura T; Numata Y; Nakamura S; Hirano E; Gotoh L; Goto YI; Urushitani M; Inoue K
Exp Biol Med (Maywood); 2014 Apr; 239(4):489-501. PubMed ID: 24521562
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
[TBL] [Abstract][Full Text] [Related]
4. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
5. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
6. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
[TBL] [Abstract][Full Text] [Related]
7. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
[TBL] [Abstract][Full Text] [Related]
8. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
Garbern JY
J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
[No Abstract] [Full Text] [Related]
9. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a PLP-overexpressing transgenic rat, a model for the connatal form of Pelizaeus-Merzbacher disease.
Mayer JA; Larsen EC; Kondo Y; Duncan ID
Neurobiol Dis; 2011 Nov; 44(2):231-8. PubMed ID: 21784154
[TBL] [Abstract][Full Text] [Related]
11. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
[TBL] [Abstract][Full Text] [Related]
12. The PLP mutants from mouse to man.
Duncan ID
J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
[No Abstract] [Full Text] [Related]
13. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
[TBL] [Abstract][Full Text] [Related]
14. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
Inoue K
Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
[TBL] [Abstract][Full Text] [Related]
16. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
Elitt MS; Tesar PJ
Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
[TBL] [Abstract][Full Text] [Related]
17. Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the Golgi apparatus associated with pathogenesis in Pelizaeus-Merzbacher disease.
Numata Y; Morimura T; Nakamura S; Hirano E; Kure S; Goto YI; Inoue K
J Biol Chem; 2013 Mar; 288(11):7451-7466. PubMed ID: 23344956
[TBL] [Abstract][Full Text] [Related]
18. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease.
Hobson G; Stabley D; Funanage V; Marks H
Hum Mutat; 2001 Feb; 17(2):152. PubMed ID: 11180600
[TBL] [Abstract][Full Text] [Related]
19. A novel PLP1 mutation associated with optic nerve enlargement in two siblings with Pelizaeus-Merzbacher disease: A new MRI finding.
Pavlidou E; Ramachandran V; Govender V; Wilson C; Das R; Vlachou V; Pavlou E; Saggar A; Mankad K; Kinali M
Brain Dev; 2017 Mar; 39(3):271-274. PubMed ID: 27793435
[TBL] [Abstract][Full Text] [Related]
20. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
